10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021

American Diabetes Association - Diabetes care, 2021 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …

Treatment of NAFLD with diet, physical activity and exercise

M Romero-Gómez, S Zelber-Sagi, M Trenell - Journal of hepatology, 2017 - Elsevier
Lifestyle intervention can be effective when treating non-alcoholic fatty liver diseases
(NAFLD) patients. Weight loss decreases cardiovascular and diabetes risk and can also …

Obesity, risk of diabetes and role of physical activity, exercise training and cardiorespiratory fitness

S Carbone, MG Del Buono, C Ozemek… - Progress in cardiovascular …, 2019 - Elsevier
The epidemic of obesity contributes to the burden of type 2 diabetes mellitus (T2DM) in the
United States and worldwide. Importantly, obesity is not only preventable but can be treated …

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the …

MJ Davies, VR Aroda, BS Collins, RA Gabbay, J Green… - Diabetologia, 2022 - Springer
Abstract The American Diabetes Association and the European Association for the Study of
Diabetes convened a panel to update the previous consensus statements on the …

[HTML][HTML] Physical activity/exercise and diabetes: a position statement of the American Diabetes Association

SR Colberg, RJ Sigal, JE Yardley, MC Riddell… - Diabetes …, 2016 - ncbi.nlm.nih.gov
The adoption and maintenance of physical activity are critical foci for blood glucose
management and overall health in individuals with diabetes and prediabetes …

Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications

HJL Heerspink, BA Perkins, DH Fitchett, M Husain… - Circulation, 2016 - Am Heart Assoc
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, including empagliflozin, dapagliflozin,
and canagliflozin, are now widely approved antihyperglycemic therapies. Because of their …

Insulin resistance and atherosclerosis: implications for insulin-sensitizing agents

A Di Pino, RA DeFronzo - Endocrine reviews, 2019 - academic.oup.com
Patients with type 2 diabetes mellitus (T2DM) are at high risk for macrovascular
complications, which represent the major cause of mortality. Despite effective treatment of …

Exercise as medicine–evidence for prescribing exercise as therapy in 26 different chronic diseases

BK Pedersen, B Saltin - … journal of medicine & science in sports, 2015 - Wiley Online Library
This review provides the reader with the up‐to‐date evidence‐based basis for prescribing
exercise as medicine in the treatment of 26 different diseases: psychiatric diseases …

[HTML][HTML] Lixisenatide in patients with type 2 diabetes and acute coronary syndrome

MA Pfeffer, B Claggett, R Diaz… - … England Journal of …, 2015 - Mass Medical Soc
Background Cardiovascular morbidity and mortality are higher among patients with type 2
diabetes, particularly those with concomitant cardiovascular diseases, than in most other …

Causal associations between cardiorespiratory fitness and type 2 diabetes

L Cai, T Gonzales, E Wheeler, ND Kerrison… - Nature …, 2023 - nature.com
Higher cardiorespiratory fitness is associated with lower risk of type 2 diabetes. However,
the causality of this relationship and the biological mechanisms that underlie it are unclear …